Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and tolerability of captopril ointment in psoriasis vulgaris
2008-006004-36Phase 2Completed
- Sponsor
- ACE Biotechnology
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of captopril in plaque psoriasis (4 arms), sponsored by ACE Biotechnology. Primary endpoint: Objective clinical assessment of psoriasis. Started Nov 2008; status: completed.
02
Drugs
captopril
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2008-006004-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006004-36.